Inherited cardiac muscle disease: Dilated cardiomyopathy

Eloisa Arbustini, Lorenzo Giuliani, Alessandro Di Toro, Valentina Favalli

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Dilated cardiomyopathy (DCM) is a chronic primary heart muscle disease defined by "the presence of unexplained dilatation and systolic impairment of the left or both ventricles". It represents the end-phenotype of heart muscle damage induced by different genetic (>100 known disease genes) and nongenetic causes (inflammatory, toxic, and immune-mediated). In familial genetic DCM, the most common inheritance is autosomal dominant irrespective of the possible complex genetics (> than one mutation) identifiable with the modern massive parallel sequencing of multi-gene panels. The precise diagnosis (identification of the cause) starts with clinical hypothesis that should be generated on the basis of deep phenotyping of the proband and relatives, clinical history and pathology investigations. Genetic tests in probands and cascade family screening in clinically phenotyped families provide the basis for segregation studies that are major contributors to the assignment of a causative role of mutations in families.

Original languageEnglish
Title of host publicationCardiovascular Genetics and Genomics
Subtitle of host publicationPrinciples and Clinical Practice
PublisherSpringer International Publishing AG
Pages319-366
Number of pages48
ISBN (Electronic)9783319661148
ISBN (Print)9783319661124
DOIs
Publication statusPublished - Jan 17 2018
Externally publishedYes

Fingerprint

Dilated Cardiomyopathy
Muscle
Heart Diseases
Myocardium
Genes
Mutation
Clinical Pathology
Poisons
Pathology
Dilatation
Screening
Phenotype
Familial dilated cardiomyopathy
Genetics

Keywords

  • Arrhythmogenic Mithocondrial
  • DCM clinical cases
  • Dystrophin
  • Familial
  • Genetic dilated cardiomyopathies
  • Mutation Lamin
  • Myopathy
  • Nebulette
  • Peripartum
  • Phospholamban

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Arbustini, E., Giuliani, L., Di Toro, A., & Favalli, V. (2018). Inherited cardiac muscle disease: Dilated cardiomyopathy. In Cardiovascular Genetics and Genomics: Principles and Clinical Practice (pp. 319-366). Springer International Publishing AG. https://doi.org/10.1007/978-3-319-66114-8_10

Inherited cardiac muscle disease : Dilated cardiomyopathy. / Arbustini, Eloisa; Giuliani, Lorenzo; Di Toro, Alessandro; Favalli, Valentina.

Cardiovascular Genetics and Genomics: Principles and Clinical Practice. Springer International Publishing AG, 2018. p. 319-366.

Research output: Chapter in Book/Report/Conference proceedingChapter

Arbustini, E, Giuliani, L, Di Toro, A & Favalli, V 2018, Inherited cardiac muscle disease: Dilated cardiomyopathy. in Cardiovascular Genetics and Genomics: Principles and Clinical Practice. Springer International Publishing AG, pp. 319-366. https://doi.org/10.1007/978-3-319-66114-8_10
Arbustini E, Giuliani L, Di Toro A, Favalli V. Inherited cardiac muscle disease: Dilated cardiomyopathy. In Cardiovascular Genetics and Genomics: Principles and Clinical Practice. Springer International Publishing AG. 2018. p. 319-366 https://doi.org/10.1007/978-3-319-66114-8_10
Arbustini, Eloisa ; Giuliani, Lorenzo ; Di Toro, Alessandro ; Favalli, Valentina. / Inherited cardiac muscle disease : Dilated cardiomyopathy. Cardiovascular Genetics and Genomics: Principles and Clinical Practice. Springer International Publishing AG, 2018. pp. 319-366
@inbook{cba037d5f3e84ed9885f601fde8efc46,
title = "Inherited cardiac muscle disease: Dilated cardiomyopathy",
abstract = "Dilated cardiomyopathy (DCM) is a chronic primary heart muscle disease defined by {"}the presence of unexplained dilatation and systolic impairment of the left or both ventricles{"}. It represents the end-phenotype of heart muscle damage induced by different genetic (>100 known disease genes) and nongenetic causes (inflammatory, toxic, and immune-mediated). In familial genetic DCM, the most common inheritance is autosomal dominant irrespective of the possible complex genetics (> than one mutation) identifiable with the modern massive parallel sequencing of multi-gene panels. The precise diagnosis (identification of the cause) starts with clinical hypothesis that should be generated on the basis of deep phenotyping of the proband and relatives, clinical history and pathology investigations. Genetic tests in probands and cascade family screening in clinically phenotyped families provide the basis for segregation studies that are major contributors to the assignment of a causative role of mutations in families.",
keywords = "Arrhythmogenic Mithocondrial, DCM clinical cases, Dystrophin, Familial, Genetic dilated cardiomyopathies, Mutation Lamin, Myopathy, Nebulette, Peripartum, Phospholamban",
author = "Eloisa Arbustini and Lorenzo Giuliani and {Di Toro}, Alessandro and Valentina Favalli",
year = "2018",
month = "1",
day = "17",
doi = "10.1007/978-3-319-66114-8_10",
language = "English",
isbn = "9783319661124",
pages = "319--366",
booktitle = "Cardiovascular Genetics and Genomics",
publisher = "Springer International Publishing AG",
address = "Switzerland",

}

TY - CHAP

T1 - Inherited cardiac muscle disease

T2 - Dilated cardiomyopathy

AU - Arbustini, Eloisa

AU - Giuliani, Lorenzo

AU - Di Toro, Alessandro

AU - Favalli, Valentina

PY - 2018/1/17

Y1 - 2018/1/17

N2 - Dilated cardiomyopathy (DCM) is a chronic primary heart muscle disease defined by "the presence of unexplained dilatation and systolic impairment of the left or both ventricles". It represents the end-phenotype of heart muscle damage induced by different genetic (>100 known disease genes) and nongenetic causes (inflammatory, toxic, and immune-mediated). In familial genetic DCM, the most common inheritance is autosomal dominant irrespective of the possible complex genetics (> than one mutation) identifiable with the modern massive parallel sequencing of multi-gene panels. The precise diagnosis (identification of the cause) starts with clinical hypothesis that should be generated on the basis of deep phenotyping of the proband and relatives, clinical history and pathology investigations. Genetic tests in probands and cascade family screening in clinically phenotyped families provide the basis for segregation studies that are major contributors to the assignment of a causative role of mutations in families.

AB - Dilated cardiomyopathy (DCM) is a chronic primary heart muscle disease defined by "the presence of unexplained dilatation and systolic impairment of the left or both ventricles". It represents the end-phenotype of heart muscle damage induced by different genetic (>100 known disease genes) and nongenetic causes (inflammatory, toxic, and immune-mediated). In familial genetic DCM, the most common inheritance is autosomal dominant irrespective of the possible complex genetics (> than one mutation) identifiable with the modern massive parallel sequencing of multi-gene panels. The precise diagnosis (identification of the cause) starts with clinical hypothesis that should be generated on the basis of deep phenotyping of the proband and relatives, clinical history and pathology investigations. Genetic tests in probands and cascade family screening in clinically phenotyped families provide the basis for segregation studies that are major contributors to the assignment of a causative role of mutations in families.

KW - Arrhythmogenic Mithocondrial

KW - DCM clinical cases

KW - Dystrophin

KW - Familial

KW - Genetic dilated cardiomyopathies

KW - Mutation Lamin

KW - Myopathy

KW - Nebulette

KW - Peripartum

KW - Phospholamban

UR - http://www.scopus.com/inward/record.url?scp=85046117953&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046117953&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-66114-8_10

DO - 10.1007/978-3-319-66114-8_10

M3 - Chapter

AN - SCOPUS:85046117953

SN - 9783319661124

SP - 319

EP - 366

BT - Cardiovascular Genetics and Genomics

PB - Springer International Publishing AG

ER -